Dr. Sarah Diermeier is a Lecturer in the Department of Biochemistry at the University of Otago with an interest in identifying novel therapeutic targets and cancer. Dr. Diermeier received her PhD in 2013 from the University of Regensburg, Germany. From 2013–2018 she conducted research at the Cold Spring Harbor Laboratory, NY, USA. In 2016, she was awarded a Susan G. Komen postdoctoral fellowship, and in 2017, a K99/R00 Pathway to Independence Award by the United States National Cancer Institute and the National Institutes of Health. Dr. Diermeier rescinded this prestigious award to move to New Zealand, where she recently took up a lectureship at the University of Otago. In her New Zealand laboratory, she currently supervises a postdoctoral fellow, an assistant research fellow, two Honours students and a Master's student. The overarching questions of her research group are to identify novel therapeutic targets in cancer and to elucidate the genetic and epigenetic mechanisms of cancer gene regulation.